Tag: high-fidelity long-read sequencing market growth

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

High-Fidelity Long-Read Sequencing Market Growth From $1.88 Billion In 2026 To $4.22 Billion By 2030 At A CAGR Of 22.5%

The high-fidelity long-read sequencing market has experienced rapid expansion over the last few years. Projections indicate it will expand from $1.53 billion in 2025 to $1.88 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.2%. Historically, this growth has stemmed from breakthroughs in sequencing chemistry precision, initial uptake within genomics research facilities, the proliferation of extensive genome initiatives, a rising need for structural variant assessment, and enhancements in sequencing hardware capabilities.

The high-fidelity long-read sequencing market size is anticipated to undergo significant expansion in the coming years, with projections indicating a growth to $4.22 billion by 2030, reflecting a compound annual growth rate (CAGR) of 22.5%. This projected growth during the forecast period is primarily driven by factors such as the increasing implementation of precision medicine strategies, greater investments in genomics-focused drug discovery, an expansion in rare disease research, the rising clinical integration of long-read sequencing, and continuous improvements in sequencing cost efficiency. Key trends expected over the forecast period include the broader acceptance of long-read sequencing in clinical diagnostics, an escalating demand for highly accurate variant detection, the growing application of de novo genome assembly techniques, an expansion in epigenetic and transcriptomic analysis applications, and enhanced integration of sophisticated bioinformatics tools.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

High-Fidelity Long-Read Sequencing Market Expansion Drivers: What Is Shaping Future Growth?

The increasing occurrence of rare diseases is anticipated to boost the growth of the HiFi long-read sequencing market in the future. Rare diseases are conditions that affect a limited number of individuals, often presenting with intricate symptoms and restricted treatment options. The rise in rare diseases is attributed to advancements in genetic sequencing and diagnostic technologies, which facilitate earlier and more accurate identification of previously undiagnosed or misclassified conditions. HiFi long-read sequencing helps address rare diseases by enabling highly accurate, comprehensive detection of complex genetic variations frequently overlooked by short-read sequencing, thereby leading to faster and more precise diagnoses. For instance, in July 2023, according to the Department of Health & Social Care, a UK-based government department, it is estimated that more than 7,000 rare diseases exist, with new conditions consistently being discovered as research progresses. Approximately 80% of these rare diseases are known to have a genetic basis. Therefore, the growing incidence of rare diseases is driving the expansion of the HiFi long-read sequencing market.

High-Fidelity Long-Read Sequencing Market Segment Outlook: Which Categories Are Expanding The Fastest?

The high-fidelity long-read sequencing market covered in this report is segmented –

1) By Product Type: Instruments; Consumables; Software

2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies

3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications

4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments

2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes

3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software

High-Fidelity Long-Read Sequencing Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Companies operating within the HiFi long-read sequencing market are concentrating on developing advanced solutions, such as hybrid-capture target enrichment. These efforts aim to boost sequencing accuracy, broaden coverage of intricate genomic regions, and hasten the identification of structural variants for sophisticated research and clinical uses. Hybrid-capture target enrichment refers to a genomic sequencing method that selectively separates specific DNA or RNA regions from a sample using complementary probes. This allows for focused, highly accurate sequencing of target areas while minimizing the sequencing of non-relevant segments. For example, in July 2025, QIAGEN N.V., a biotechnology company based in the Netherlands, released its QIAseq xHYB Long Read Panels, expanding its range of next-generation sequencing (NGS) products. This product utilizes hybrid-capture enrichment to facilitate accurate long-read sequencing of complex genomic areas like repeats and structural variants, overcoming the drawbacks of short-read methods. The panels deliver outstanding uniformity, specificity, and full coverage for applications such as cancer profiling, HLA typing, and haplotype phasing. They come in adaptable fixed or custom formats and support integrated workflows from DNA preparation to bioinformatics analysis. Benefits include improved efficiency and more in-depth insights for precision medicine.

High-Fidelity Long-Read Sequencing Market Key Companies And Competitive Benchmarking

Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.

Access The Complete High-Fidelity Long-Read Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

High-Fidelity Long-Read Sequencing Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The High-Fidelity Long-Read Sequencing Market In 2026 And 2030?

The high-fidelity long-read sequencing market size has seen substantial growth in recent years. It is expected to expand from $1.53 billion in 2025 to $1.88 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 22.2%. This historical growth can be attributed to several factors, including improvements in sequencing chemistry accuracy, initial adoption within genomics research institutions, the expansion of large-scale genome projects, increasing demand for structural variant analysis, and advancements in sequencing hardware performance.

The high-fidelity long-read sequencing market is projected to experience rapid expansion over the coming years. This market is anticipated to reach $4.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.5%. This expansion during the projected timeframe is driven by factors such as the increasing application of precision medicine, heightened investments in genomics-based drug discovery, the broadening scope of rare disease research, greater clinical implementation of long-read sequencing, and improvements in sequencing cost-effectiveness. Key trends for this period encompass the growing integration of long-read sequencing into clinical diagnostics, an escalating need for highly accurate variant detection, the expanding utilization of de novo genome assembly techniques, the widening range of epigenetic and transcriptomic analysis applications, and improved incorporation of advanced bioinformatics tools.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp

Which Growth Drivers Are Expected To Support The High-Fidelity Long-Read Sequencing Market Forward?

The growing prevalence of rare diseases is anticipated to drive the expansion of the HiFi long-read sequencing market moving forward. These rare conditions are disorders that impact a small number of individuals, often characterized by complex symptoms and limited treatment avenues. The increase in rare diseases is attributed to advancements in genetic sequencing and diagnostic technologies, which allow for earlier and more accurate identification of previously undiagnosed or misclassified conditions. HiFi long-read sequencing aids in tackling rare diseases by enabling highly accurate, exhaustive detection of intricate genetic variants frequently overlooked by short-read sequencing, thereby leading to faster and more precise diagnoses. For instance, in July 2023, according to the Department of Health & Social Care, a UK-based government department, it is estimated that more than 7,000 rare diseases exist, with new conditions continually being discovered as research advances. Approximately 80% of these rare diseases are known to have a genetic basis. Consequently, the rising occurrence of rare diseases is fostering the growth of the HiFi long-read sequencing market.

How Is Segment Classification Applied In The High-Fidelity Long-Read Sequencing Market?

The high-fidelity long-read sequencing market covered in this report is segmented –

1) By Product Type: Instruments; Consumables; Software

2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies

3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications

4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments

2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes

3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software

What Trends Are Influencing The Future Of The High-Fidelity Long-Read Sequencing Market?

Major companies operating in the HiFi long-read sequencing market are focusing on developing innovative solutions, such as hybrid-capture target enrichment, to enhance sequencing accuracy, increase coverage of complex genomic regions, and accelerate the detection of structural variants for advanced research and clinical applications. Hybrid-capture target enrichment refers to a genomic sequencing technique that selectively isolates specific regions of DNA or RNA from a sample using complementary probes, allowing for focused, high-accuracy sequencing of target regions while reducing the analysis of non-relevant regions. For instance, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) offerings. This product uses hybrid-capture enrichment to enable precise long-read sequencing of complex genomic regions like repeats and structural variants, overcoming short-read limitations. These panels offer superior uniformity, specificity, and complete coverage for applications in cancer profiling, HLA typing, and haplotype phasing, with flexible fixed or custom formats and integrated workflows from DNA prep to bioinformatics analysis. Benefits include streamlined efficiency and deeper insights for precision medicine.

Which Organizations Are Involved In The High-Fidelity Long-Read Sequencing Market?

Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.

Access The Complete High-Fidelity Long-Read Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report

Which Region Stands As The Largest Contributor To The High-Fidelity Long-Read Sequencing Market?

North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized High-Fidelity Long-Read Sequencing Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The High-Fidelity Long-Read Sequencing Market Progress Between 2026 And 2030?

The market size for high-fidelity long-read sequencing has experienced substantial growth in recent years. It is anticipated to increase from $1.53 billion in 2025 to $1.88 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.2%. The historical growth in this sector is attributable to advancements in sequencing chemistry accuracy, early adoption in genomics research institutions, expansion of large-scale genome projects, increasing demand for structural variant analysis, and improvements in sequencing hardware performance.

The high-fidelity long-read sequencing market is anticipated to experience substantial growth in the coming years. It is projected to reach $4.22 billion by 2030, growing at a compound annual growth rate (CAGR) of 22.5%. This expansion during the forecast period is fueled by factors such as the expanding application of precision medicine approaches, increasing investments in genomics-based drug discovery, the broadening scope of rare disease research, greater clinical adoption of long-read sequencing, and improvements in sequencing cost efficiency. Key trends for this period include the rising incorporation of long-read sequencing in clinical diagnostics, a heightened demand for high-accuracy variant detection, the increasing use of de novo genome assembly techniques, an expansion in epigenetic and transcriptomic analysis applications, and enhanced integration of advanced bioinformatics tools.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp

Which Important Drivers Are Guiding The High-Fidelity Long-Read Sequencing Market Growth?

The growing incidence of rare diseases is projected to stimulate the HiFi long-read sequencing market’s expansion moving forward. These conditions are characterized by impacting a small segment of the population, often presenting intricate symptoms and limited therapeutic options. The increase in rare diseases is attributed to advancements in genetic sequencing and diagnostic technologies, which facilitate earlier and more precise identification of previously unrecognized or misdiagnosed conditions. HiFi long-read sequencing offers a solution for rare diseases by enabling highly accurate and comprehensive detection of complex genetic variations frequently overlooked by short-read sequencing, thereby leading to quicker and more accurate diagnoses. For instance, in July 2023, the Department of Health & Social Care, a UK-based government body, estimated that there are over 7,000 rare diseases, with new ones continuously being identified as research advances. Approximately 80% of these rare diseases are known to have a genetic foundation. Consequently, the increasing prevalence of rare diseases is a key factor propelling the growth of the HiFi long-read sequencing market.

How Is Segmentation Applied In The High-Fidelity Long-Read Sequencing Market Segment Analysis?

The high-fidelity long-read sequencing market covered in this report is segmented –

1) By Product Type: Instruments; Consumables; Software

2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies

3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications

4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments

2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes

3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software

What Trends Are Influencing The Evolution Of The High-Fidelity Long-Read Sequencing Market?

Leading companies in the HiFi long-read sequencing market are concentrating on developing innovative solutions, such as hybrid-capture target enrichment, to enhance sequencing accuracy, increase coverage of complex genomic regions, and accelerate the detection of structural variants for advanced research and clinical applications. Hybrid-capture target enrichment refers to a genomic sequencing technique that selectively isolates specific regions of DNA or RNA from a sample using complementary probes, allowing for focused, high-accuracy sequencing of target regions while reducing sequencing of non-relevant areas. For instance, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) offerings. These panels utilize hybrid-capture enrichment to enable precise long-read sequencing of complex genomic regions like repeats and structural variants, overcoming short-read limitations. They provide superior uniformity, specificity, and complete coverage for applications in cancer profiling, HLA typing, and haplotype phasing, with flexible fixed or custom formats and integrated workflows from DNA prep to bioinformatics analysis. Benefits include streamlined efficiency and deeper insights for precision medicine.

Who Are The Companies Participating In The High-Fidelity Long-Read Sequencing Market Environment?

Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.

Get The Full High-Fidelity Long-Read Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report

Where Is The High-Fidelity Long-Read Sequencing Market Primarily Concentrated By Region?

North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized High-Fidelity Long-Read Sequencing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=33166&type=smp

Browse Through More Reports Similar to the Global High-Fidelity Long-Read Sequencing Market 2026, By The Business Research Company

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Short Read Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

Clinical Oncology Next Generation Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The High-Fidelity Long-Read Sequencing Market By The End Of 2030?

The high-fidelity long-read sequencing market has witnessed significant expansion in recent years. Its value is projected to climb from $1.53 billion in 2025 to $1.88 billion in 2026, with a compound annual growth rate (CAGR) of 22.2%. Historically, this market’s growth has been fueled by progress in sequencing chemistry accuracy, early integration into genomics research institutions, the proliferation of large-scale genome projects, a rising requirement for structural variant analysis, and enhancements in sequencing hardware performance.

The high-fidelity long-read sequencing market is anticipated to experience substantial growth over the coming years, projected to reach $4.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.5%. This projected expansion during the forecast period is fueled by several factors, including the increasing application of precision medicine, heightened investments in genomics-driven drug discovery, the broadening scope of rare disease research, the growing clinical integration of long-read sequencing, and improvements in sequencing cost-effectiveness. Key developments shaping this period include the increased acceptance of long-read sequencing within clinical diagnostics, a rising need for highly accurate variant detection, the expanded utilization of de novo genome assembly methods, the wider application of epigenetic and transcriptomic analysis, and the improved integration of sophisticated bioinformatics tools.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp

Which Major Factors Are Driving The Expansion Of The High-Fidelity Long-Read Sequencing Market?

The increasing occurrence of rare diseases is anticipated to boost the expansion of the HiFi long-read sequencing market in the future. These conditions affect a limited number of people, typically characterized by intricate symptoms and restricted treatment avenues. The rise in rare diseases stems from progress in genetic sequencing and diagnostic methods, allowing for quicker and more precise detection of conditions previously unidentified or incorrectly classified. HiFi long-read sequencing contributes to managing rare diseases by facilitating highly accurate and thorough identification of intricate genetic variations frequently overlooked by short-read sequencing, thereby resulting in swifter and more accurate diagnoses. For example, in July 2023, the Department of Health & Social Care, a government body in the UK, reported an estimated existence of over 7,000 rare diseases, with ongoing research continually uncovering new ones. About 80% of these conditions are recognized to have a genetic origin. Consequently, the growing incidence of rare diseases is fueling the expansion of the HiFi long-read sequencing market.

Which Segment Classifications Shape The High-Fidelity Long-Read Sequencing Market?

The high-fidelity long-read sequencing market covered in this report is segmented –

1) By Product Type: Instruments; Consumables; Software

2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies

3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications

4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments

2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes

3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software

How Are Trends Impacting The High-Fidelity Long-Read Sequencing Market?

Leading companies within the HiFi long-read sequencing market are concentrating on developing innovative solutions, such as hybrid-capture target enrichment, to improve sequencing accuracy, broaden coverage of intricate genomic regions, and accelerate the identification of structural variants for advanced research and clinical uses. Hybrid-capture target enrichment is a genomic sequencing technique that specifically isolates particular DNA or RNA regions from a sample using complementary probes, enabling focused, high-accuracy sequencing of target areas while minimizing the sequencing of irrelevant sections. For example, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, introduced QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) portfolio. These panels utilize hybrid-capture enrichment to facilitate precise long-read sequencing of complex genomic regions, including repeats and structural variants, effectively overcoming the limitations of short-read technologies. They provide superior uniformity, specificity, and complete coverage for various applications, such as cancer profiling, HLA typing, and haplotype phasing, offering flexible fixed or custom formats and integrated workflows from DNA preparation to bioinformatics analysis. The advantages include streamlined efficiency and deeper insights, especially for precision medicine.

Who Are The Primary Competitors In The High-Fidelity Long-Read Sequencing Market?

Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.

Read the full high-fidelity long-read sequencing market report here:

https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report

Which Region Is Anticipated To See The Fastest Growth In The High-Fidelity Long-Read Sequencing Market?

North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored High-Fidelity Long-Read Sequencing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33166&type=smp

Browse Through More Reports Similar to the Global High-Fidelity Long-Read Sequencing Market 2026, By The Business Research Company

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Short Read Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

Clinical Oncology Next Generation Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the high-fidelity long-read sequencing market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the High-Fidelity Long-Read Sequencing Market?

The high-fidelity long-read sequencing market has experienced rapid expansion over recent years. It is projected to increase from $1.53 billion in 2025 to $1.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.2%. Historically, this growth was driven by advancements in sequencing chemistry accuracy, early adoption in genomics research institutions, expansion of large-scale genome projects, increasing demand for structural variant analysis, and improvements in sequencing hardware performance.

The high-fidelity long-read sequencing market is projected to experience rapid expansion in the coming years, with its valuation anticipated to reach $4.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.5%. This growth during the projected timeframe can be ascribed to factors such as the increasing application of precision medicine approaches, heightened investments in genomics-based drug discovery, the expansion of rare disease research, greater clinical integration of long-read sequencing, and advancements in sequencing cost efficiency. Key trends for this period encompass the wider implementation of long-read sequencing in clinical diagnostics, an escalating need for high-accuracy variant detection, the expanding utilization of de novo genome assembly techniques, the broadening scope of epigenetic and transcriptomic analysis applications, and improved incorporation of sophisticated bioinformatics tools.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp

Which Drivers Are Supporting The Rise Of The High-Fidelity Long-Read Sequencing Market?

The increasing occurrence of rare diseases is anticipated to boost the expansion of the HiFi long-read sequencing market in the future. These disorders affect a small population, typically presenting with intricate symptoms and few therapeutic avenues. The rise in rare diseases can be attributed to advancements in genetic sequencing and diagnostic methods, facilitating earlier and more precise identification of conditions previously overlooked or incorrectly categorized. HiFi long-read sequencing plays a crucial role in tackling rare diseases by allowing for highly accurate, all-encompassing detection of intricate genetic variations frequently overlooked by short-read sequencing, thereby resulting in quicker and more accurate diagnoses. For example, as reported by the Department of Health & Social Care, a UK-based government department, in July 2023, there are an estimated more than 7,000 rare diseases, with new ones continuously being identified through ongoing research. It is understood that around 80% of these rare diseases have a genetic foundation. This growing occurrence of rare diseases is, therefore, fueling the development of the HiFi long-read sequencing market.

What Leading Segments Are Studied In The High-Fidelity Long-Read Sequencing Market?

The high-fidelity long-read sequencing market covered in this report is segmented –

1) By Product Type: Instruments; Consumables; Software

2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies

3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications

4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments

2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes

3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software

Which Market Trends Are Opening Growth Opportunities In The High-Fidelity Long-Read Sequencing Market?

Major companies operating within the HiFi long-read sequencing market are concentrating on developing innovative solutions, such as hybrid-capture target enrichment, to enhance sequencing accuracy, increase coverage of complex genomic regions, and accelerate the detection of structural variants for advanced research and clinical applications. Hybrid-capture target enrichment denotes a genomic sequencing technique that selectively isolates specific regions of DNA or RNA from a sample using complementary probes, enabling focused, high-accuracy sequencing of target regions while reducing the sequencing of non-relevant regions. For instance, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, introduced QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) offerings. This product utilizes hybrid-capture enrichment to facilitate precise long-read sequencing of intricate genomic regions like repeats and structural variants, thereby overcoming short-read limitations. They offer exceptional uniformity, specificity, and comprehensive coverage for applications in cancer profiling, HLA typing, and haplotype phasing, with flexible fixed or custom formats and integrated workflows from DNA prep to bioinformatics analysis, providing streamlined efficiency and deeper insights for precision medicine.

Which Major Firms Are Strengthening Their Position In The High-Fidelity Long-Read Sequencing Market?

Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report

Which Region Shows The Strongest Potential For Future Expansion In The High-Fidelity Long-Read Sequencing Market?

North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized High-Fidelity Long-Read Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33166&type=smp

Browse Through More Reports Similar to the Global High-Fidelity Long-Read Sequencing Market 2026, By The Business Research Company

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Short Read Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

Clinical Oncology Next Generation Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model